awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26738940-14D6F98D-7E1E-4D46-993E-C9EEFDFFCB1C
Q26738940-14D6F98D-7E1E-4D46-993E-C9EEFDFFCB1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738940-14D6F98D-7E1E-4D46-993E-C9EEFDFFCB1C
Bortezomib for the treatment of mantle cell lymphoma: an update
P2860
Q26738940-14D6F98D-7E1E-4D46-993E-C9EEFDFFCB1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738940-14D6F98D-7E1E-4D46-993E-C9EEFDFFCB1C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7bb939895bf2cc5e2429e93ba991c02db7b03842
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).